Correction to: Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study

Hidenobu Tanihara,Takahiko Kakuda,Tetsuro Sano,Takashi Kanno,Ryosuke Imada,Wataru Shingaki,Ryoji Gunji

Correction to: Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study

2019

Hidenobu Tanihara
Takahiko Kakuda
Tetsuro Sano
Takashi Kanno
Ryosuke Imada
Wataru Shingaki
Ryoji Gunji

Introduction To evaluate the safety and intraocular pressure (IOP)-lowering effects of a ripasudil 0.4% ophthalmic solution in Japanese patients with glaucoma and ocular hypertension (OH) as a post-marketing surveillance.

Keywords:

Glaucoma
Anesthesia
Intraocular pressure
Ophthalmology
Ripasudil
Interim analysis
Diabetes mellitus
Ocular hypertension
Postmarketing surveillance
Medicine
Discontinuation
Normal tension glaucoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations